| 溴吡斯的明口腔崩解片的研制及质量控制 |
| |
| 引用本文： | 张梨,谭群友,程训官,王红,胡霓霓,张景勍. 溴吡斯的明口腔崩解片的研制及质量控制[J]. 四川大学学报(医学版), 2012, 43(3): 458-461,477 |
| |
| 作者姓名： | 张梨 谭群友 程训官 王红 胡霓霓 张景勍 |
| |
| 作者单位： | 张梨 (重庆医科大学 药物高校工程研究中心和生物化学与分子药理学重点实验室,重庆,400016) ； 谭群友 (第三军医大学大坪医院野战外科研究所胸外科,重庆,400042) ； 程训官 (重庆医科大学药物化学与生物材料研究室,重庆,400016) ； 王红 (重庆医科大学 药物高校工程研究中心和生物化学与分子药理学重点实验室,重庆,400016) ； 胡霓霓 (重庆医科大学 药物高校工程研究中心和生物化学与分子药理学重点实验室,重庆,400016) ； 张景勍 (重庆医科大学 药物高校工程研究中心和生物化学与分子药理学重点实验室,重庆,400016) ； |
| |
| 基金项目： | 教育部博士点基金,重庆市教育委员会(首批高等学校优秀人才资助) |
| |
| 摘 要： | 目的制备口感良好的溴吡斯的明口腔崩解片,并优化处方。方法采用溶剂蒸发-沉积法制备固体分散体掩盖药物苦味,以崩解时间为指标,采用星点设计-效应面法优化处方。结果制备的口腔崩解片表面完整光洁,口感良好,能在30s内崩解完全。在水中0.5min内的药物溶出率约为8.5%,释药量约为2.5mg,低于苦味阈值(约3mg);在0.1mol/L盐酸介质中,2min累积溶出率大于95%。结论制备的口腔崩解片处方合理,工艺可行,方便患者服用。
|
| 关 键 词： | 溴吡斯的明 星点设计 效应面法 口腔崩解片 |
Preparation and Quality Control of Pyridostigmine Bromide Orally Disintegrating Tablet |
| |
| ZHANG Li,TAN Qun-you,CHENG Xun-guan,WANG Hong,HU Ni-ni,ZHANG Jing-. Preparation and Quality Control of Pyridostigmine Bromide Orally Disintegrating Tablet[J]. Journal of Sichuan University. Medical science edition, 2012, 43(3): 458-461,477 |
| |
| Authors: | ZHANG Li TAN Qun-you CHENG Xun-guan WANG Hong HU Ni-ni ZHANG Jing- |
| |
| Affiliation: | qing1.1.Medicine Engineering Research Center in University,Chongqing Key Laboratory of Biochemical & Molecular Pharmacology,Chongqing Medical University,Chongqing 400016,China;2.Department of Thoracic Surgery,Institute of Surgery Research,Daping Hospital,Third Military Medical University,Chongqing 400042,China;3.Research Lab.of Medicinal Chemistry and Biological Material,Chongqing Medical University,Chongqing 400016,China |
| |
| Abstract: | Objective To prepare orally disintegrating tablets containing pyridostigmine bromide and optimize formulations.Methods Solid dispersion was prepared using solvent evaporation-deposition method.The formulation was optimized by central composite design-response surface methodology(RSM plus CCD) with disintegration time as a reference parameter.Results The orally disintegrating tablets showed integrity and were smooth with desirable taste and feel in mouth.The disintegration time was less than 30 s.The cumulative drug dissolution was around 8.5%(around 2.5 mg which was less than bitterness threshold of pyridostigmine bromide of 3 mg) within 5 min in water while the cumulative drug dissolution was higher than 95% within 2 min in 0.1 N HCl.Conclusion The orally disintegrating tablets are reasonable in formulation,feasible in technology and patient-friendly. |
| |
| Keywords: | Pyridostigmine bromide Central composite design Response surface methodology Orally disintegrating tablet |
| 本文献已被 CNKI 等数据库收录！ |
|
